CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Rosemary Harrison Joins TCR Therapeutics as Chief Business and Strategy Officer

Rosemary Harrison Joins TCR...

Clinical Research Technology Leader RealTime Secures Growth Investment from LLR Partners

Clinical Research Technology Leader...

Catalyst Biosciences Announces Major Leadership Changes

Catalyst Biosciences Announces Major...

Merakris Therapeutics Partners with Miracles In Sight Eye Bank

Merakris Therapeutics Partners with...

BetterLife- Carleton University Research Team Secures Funding form Mitacs

BetterLife- Carleton University...

ClearPoint Neuro Appoints Lynnette C. Fallon to Board of Directors

ClearPoint Neuro Appoints Lynnette C....

Marc Drimer, CPA, Joins the Board of Directors of Curative Biotechnology

Marc Drimer, CPA, Joins the Board of...

James Pekarsky Joins Gelteq as Chief Financial Officer

James Pekarsky Joins Gelteq as Chief...

Rosemary Harrison Joins TCR Therapeutics as Chief Business and Strategy Officer

Rosemary Harrison Joins TCR...

Clinical Research Technology Leader RealTime Secures Growth Investment from LLR Partners

Clinical Research Technology Leader...

Catalyst Biosciences Announces Major Leadership Changes

Catalyst Biosciences Announces Major...

Merakris Therapeutics Partners with Miracles In Sight Eye Bank

Merakris Therapeutics Partners with...

BetterLife- Carleton University Research Team Secures Funding form Mitacs

BetterLife- Carleton University...

ClearPoint Neuro Appoints Lynnette C. Fallon to Board of Directors

ClearPoint Neuro Appoints Lynnette C....

Marc Drimer, CPA, Joins the Board of Directors of Curative Biotechnology

Marc Drimer, CPA, Joins the Board of...

James Pekarsky Joins Gelteq as Chief Financial Officer

James Pekarsky Joins Gelteq as Chief...

Thermo Fisher Scientific Announces the Launch of Two New Gas Chromatography (GC) High-Resolution Mass Spectrometers (MS)

Life Sciences Review Life Sciences Review | Monday, March 15, 2021
Tweet

The Orbitrap Exploris GC 240 MS offers breakthrough performance, reliability, and the depth of analysis required to address the most complex analytical hurdles, supporting researchers to make groundbreaking discoveries.


FREMONT, CA: Addressing the demand for increased speed, flexibility, and accuracy in research applications throughout academic and industry laboratories, a new gas chromatography (GC) high-resolution mass spectrometer (MS) with unrivaled mass resolving power, sensitivity, and dynamic range provides researchers the potential to get new depths of analysis and drive scientific understanding. With new-generation system architecture and instrument control software, the system offers simple yet potential data acquisition abilities, addressing the most demanding analytical hurdles.


The Thermo Scientific Orbitrap Exploris GC 240 MS takes research potentials to a new level with a resolving power of 240,000 for accelerated innovation. By offering quantitative and qualitative information from a single injection, the new system allows precise and comprehensive compound identification, enabling researchers to make fast and accurate discoveries with confidence. As research laboratories need the versatility to answer several questions in their studies, the Orbitrap Exploris GC 240 MS also offers the flexibility to manage a diverse range of analytical hurdles, from identifying unknown contaminants and extractables leachables to applied quantification and metabolomics.


The system provides the potential of MS/MS for compound structural information and both electron and chemical ionization without system venting to accelerate time to result.


For metabolomics experiments, the potential to achieve such high selectivity and maintain sensitivity is revolutionary for the research. Having seamless access to this data certainty and such wide coverage opens up new research avenues.  Users of the Orbitrap Exploris GC 240 MS will benefit from the analytical dynamic range across six orders, offering accurate quantitation and identification of chemical components at trace and high concentrations and a standardized setup and easy-to-use system users with varying levels of technical experience.


The new system, along with the Thermo Scientific Orbitrap Exploris GC, widens the Thermo Scientific Orbitrap Exploris portfolio of high-resolution accurate-mass systems, which is now comprised of the Thermo Scientific Orbitrap Exploris 480 mass spectrometer, released in 2019, and the recently introduced Thermo Scientific Orbitrap Exploris 240 and Thermo Scientific Orbitrap Exploris 120 mass spectrometers.


Weekly Brief

loading
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial
How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/thermo-fisher-scientific-announces-the-launch-of-two-new-gas-chromatography-gc-highresolution-mass-spectrometers-ms-nwid-289.html